Ketamine: “lost in translation?”

Last month I shared a BMJ Editorial on Ketamine by Dr Sameer Jauhar and Dr Paul Morrison. Since then there have been a number of published BMJ responses and replies. … Continue reading Ketamine: “lost in translation?”

‘A warning to the NHS: don’t let big pharma loose on policy’

What follows are a few extracts from this article in today’s Observer by Chris McGreal:

“In pursuit of marketing approval” [antidepressants for anxiety]

This is a report in the current BMJ: This was the result of the pursuit of the market: The US Food and Drug Administration failed to ensure scientific objectivity: Robert … Continue reading “In pursuit of marketing approval” [antidepressants for anxiety]